LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $217,000 | -32.0% | 28,300 | +44.4% | 0.01% | +33.3% |
| Q4 2020 | $319,000 | -82.9% | 19,600 | -88.2% | 0.01% | -92.3% |
| Q4 2018 | $1,866,000 | -0.3% | 165,441 | -56.6% | 0.12% | +24.5% |
| Q4 2016 | $1,872,000 | +1601.8% | 381,507 | +1426.0% | 0.09% | +1780.0% |
| Q1 2014 | $110,000 | -91.0% | 25,000 | +7.6% | 0.01% | -86.8% |
| Q4 2013 | $1,222,000 | – | 23,232 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |